DEFA14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934 (Amendment No. )

 

Filed by the Registrant

 

Filed by a Party other than the Registrant

 

 

      

Check the appropriate box:

 

 

Preliminary Proxy Statement

 

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

 

Definitive Proxy Statement

 

 

Definitive Additional Materials

 

 

Soliciting Material under §240.14a-12

LOGICBIO THERAPEUTICS, INC.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

 

 

No fee required.

 

 

Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

  (1)

Title of each class of securities to which transaction applies:

 

  (2)

Aggregate number of securities to which transaction applies:

 

  (3)

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

  (4)

Proposed maximum aggregate value of transaction:

 

  (5)

Total fee paid:

 

 

Fee paid previously with preliminary materials.

 

  (1)

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

Amount Previously Paid:

 

  (2)

Form, Schedule or Registration Statement No.:

 

  (3)

Filing Party:

 

  (4)

Date Filed:


*** Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

Shareholder Meeting to Be Held on June 25, 2019

 

             
      Meeting Information      
   
                      LOGICBIO THERAPEUTICS, INC.     Meeting Type: Annual Meeting      
      For holders as of: April 29, 2019      
               Date: June 25, 2019             Time: 1:00 PM EST      
    Location: Ropes & Gray LLP      
                    Prudential Tower           
   

                800 Boylston Street

                Boston, MA 02199

    

 

     
         
 

LOGICBIO THERAPEUTICS, INC.

99 Erie Street

Cambridge, MA 02139

  You are receiving this communication because you hold shares in the above named company.    
LOGO  

 

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

   
   

 

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

   
     

 

See the reverse side of this notice to obtain proxy materials and voting instructions.

 

   


— Before You Vote —

How to Access the Proxy Materials

 

   

 

Proxy Materials Available to VIEW or RECEIVE:

   

1.  Form 10-K       2.  Notice & Proxy Statement

   

 

How to View Online:

   
    Have the information that is printed in the box marked by the arrow LOGO (located on the following page) and visit: www.proxyvote.com.
    How to Request and Receive a PAPER or E-MAIL Copy:
    If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
   

1) BY INTERNET:

  www.proxyvote.com    
   

2) BY TELEPHONE:

  1-800-579-1639    
   

3) BY E-MAIL*:

  sendmaterial@proxyvote.com    
   

*  If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow LOGO (located on the following page) in the subject line.

   

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before June 11, 2019 to facilitate timely delivery.

 

          

— How To Vote —

Please Choose One of the Following Voting Methods

 

         
LOGO    

 

Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

   
   

 

Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow LOGO available and follow the instructions.

   
   

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

 

   
     


       Voting items

The Board of Directors recommends you vote

FOR the following:

 

  1.

Election of Class I Directors for a three-year term

Nominees

 

  01

Erez Chimovits                     02    Mark Kay, M.D., Ph.D.

The Board of Directors recommends you vote FOR the following proposal:

 

  2

To ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2019.

NOTE: Such other business as may properly come before the meeting or any adjournment thereof.

 

LOGO   


 

 

 

  

 

 

LOGO